Welcome to our dedicated page for GENWORTH FINANCIAL SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENWORTH FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENWORTH FINANCIAL's regulatory disclosures and financial reporting.
Genworth Financial reported Q2 2026 net income available to common stockholders of $47 million, or $0.12 per diluted share. Adjusted operating income excluding the Closed Block, the company’s primary performance metric, was $112 million or $0.29 per diluted share. Results were led by majority-owned Enact, which generated $143 million of adjusted operating income, $15.2 billion of primary new insurance written, $274.0 billion of primary insurance in-force, and a 14% loss ratio. Enact’s estimated PMIERs sufficiency ratio was 161%, or $1,894 million above requirements, and it paid a quarterly dividend of $0.24 per share.
The Closed Block segment posted adjusted operating loss of $110 million, primarily from a $127 million pre-tax actual-versus-expected loss as long-term care claims rose and terminations stayed low. Legacy insurance companies’ statutory pre-tax income was $6 million, and the estimated consolidated RBC ratio was 286%, down from 289%. Holding-company cash and liquid assets were $215 million, including about $81 million held for future obligations. Genworth repurchased $62 million of shares in the quarter at an average price of $8.74, and $918 million cumulatively since program inception at an average of $6.47.
Genworth Financial Inc. filed a quarterly Form 13F holdings report as an institutional investment manager. The report is signed by Vice President and Controller Darren W. Woodell, identified as the Principal Accounting Officer, who represents that the information is true, correct, and complete.
The report is classified as a 13F HOLDINGS REPORT, meaning all reportable holdings for this manager are included. It lists 2 reportable portfolio positions with an aggregate Form 13F information table value of $486,124,194 (rounded to the nearest dollar) and indicates there are 0 other included managers.
Genworth Financial reports that Samir B. Shah, Pres. & CEO of CareScout, had 15,965 Restricted Stock Units vest and convert into an equal number of shares of Common Stock on July 13, 2026. The company withheld 8,160 shares at $9.47 per share to satisfy his tax withholding obligation. Following these compensation-related transactions, Shah directly owns 123,759 shares of Genworth common stock.
Genworth Financial announced that President and CEO Tom McInerney is taking a temporary leave of absence to focus on his health. The Board appointed current CFO Jerome Upton as Interim President and CEO, effective July 7, 2026, to maintain strategic and operational continuity.
Upton has been with Genworth and its predecessors since 1998 and became CFO in March 2023 after holding multiple senior finance and operating roles, including Deputy CFO and Controller. The company highlights that its leadership team remains in place and that it intends to continue executing Genworth’s existing strategy during the interim period.
Genworth Financial President and CEO Thomas J. McInerney reported a charitable stock gift and updated holdings in company shares. On May 27, 2026, he made a bona fide gift of 200,000 shares of Genworth common stock to a charitable organization. Following this gift, he directly holds 5,168,883 shares of common stock and indirectly holds 89,456 shares through trusts for children. The filing reflects a non-market transfer rather than an open-market purchase or sale.
Genworth Financial president and CEO Thomas J. McInerney reported selling 100,000 shares of common stock in an open‑market transaction at $9.27 per share. This Form 4 shows a net reduction in his directly owned stake.
After the sale, he directly holds 5,368,883 Genworth shares. The filing also reports 89,456 shares held indirectly through trusts for children, which are listed as holdings rather than new transactions.
Genworth Financial director Robert P. Restrepo Jr. reported an open-market sale of 50,000 shares of common stock on May 22, 2026. The weighted average sales price was $9.1211 per share, based on broker-assisted trades between $9.11 and $9.135. After these sales, he directly holds 92,655.011 shares of Genworth stock.
Genworth Financial EVP & CIO Morris C. Taylor reported routine equity compensation activity involving Restricted Stock Units. On May 21, 2026, 21,521 RSUs vested and converted into the same number of Common Stock shares, while 6,478 shares were withheld to cover tax obligations. After these transactions, Taylor directly holds 15,043 shares of Common Stock and 43,042 Restricted Stock Units, reflecting an exercise-and-hold pattern with tax withholding rather than an open-market sale.
GNW notified an intended sale of 50,000 shares of Common Stock under Rule 144 through Fidelity Brokerage Services LLC on 05/22/2026. The notice lists an aggregate amount of $456,053.37 and references two prior restricted stock vesting events of 27,413 shares on 05/18/2024 and 22,587 shares on 05/23/2025.